業績一覧
業績一覧
- Ethnic difference in lung cancer: an important issue in a globalized society.
Kawaguchi T, Mack PC.
J Thorac Dis 12:3774-3775. 2020 - The Comparison of the Efficacy of Baloxavir and Neuraminidase Inhibitors for Patients with Influenza A in Clinical Practice.
Yoshii N, Tochino Y, Fujioka M, Sakazaki H, Maruyama N, Asai K, Kakeya H, Shintaku H, Kawaguchi T.
Intern Med 59:1509-1513. 2020 - Predictive impact of low-frequency pretreatment T790M mutation in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors.
Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Yoshimoto N, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Hirata K, Koh Y, Kawaguchi T.
Lung Cancer 139:80-88. 2020 - Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H.
Intern Med 59:193-198. 2020 - Disseminated Mycobacterium abscessus subsp. massiliense infection in a Good's syndrome patient negative for human immunodeficiency virus and anti-interferon-γ autoantibody: a case report.
Imoto W, Yamada K, Hajika Y, Okamoto K, Myodo Y, Niki M, Kuwabara G, Yamairi K, Shibata W, Yoshii N, Nakaie K, Yoshizawa K, Namikawa H, Watanabe T, Asai K, Moro H, Kaneko Y, Kawaguchi T, Itoh Y, Kakeya H.
BMC Infect Dis 20:431. 2020 - A mouse model of rapidly progressive fatal haemorrhagic pneumonia caused by Stenotrophomonas maltophilia.
Imoto W, Kaneko Y, Yamada K, Kuwabara G, Yamairi K, Shibata W, Oshima K, Niki M, Nakaie K, Watanabe T, Asai K, Kawaguchi T, Kakeya H.
J Glob Antimicrob Resist 23:450-455. 2020 - Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian).
Izumi M, Suzumura T, Ogawa K, Matsumoto Y, Sawa K, Yoshimoto N, Tani Y, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kawaguchi T.
J Thorac Dis 12:3776-3784. 2020 - Can smoking duration alone replace pack-years to predict the risk of smoking- related oncogenic mutations in non-small cell lung cancer? A cross-sectional study in Japan.
Ogawa K, Koh Y, Kaneda H, Izumi M, Matsumoto Y, Sawa K, Fukui M, Taniguchi Y, Yoshimoto N, Tamiya A, Ando M, Kubo A, Isa SI, Saka H, Matsumura A, Kawaguchi T.
BMJ Open 10:e035615. 2020 - Early-onset meningitis associated with atezolizumab treatment for non-small cell lung cancer: case report and literature review.
Ogawa K, Kaneda H, Kawamoto T, Tani Y, Izumi M, Matsumoto Y, Sawa K, Suzumura T, Watanabe T, Mitsuoka S, Asai K, Kawaguchi T.
Invest New Drugs 38:1901-1905. 2020 - The effect of intervention by an antimicrobial stewardship team on anaerobic bacteremia.
Kuwabara G, Yukawa S, Yamada K, Imoto W, Yamairi K, Shibata W, Yoshii N, Watanabe T, Asai K, Niki M, Nakaie K, Okada Y, Fujita A, Kaneko Y, Kawaguchi T, Kakeya H.
Anaerobe 64:102214. 2020 - Ninjin'yoeito Ameliorates Skeletal Muscle Complications in COPD Model Mice by Upregulating Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Expression.
Miyamoto A, Asai K, Kadotani H, Maruyama N, Kubo H, Okamoto A, Sato K, Yamada K, Ijiri N, Watanabe T, Kawaguchi T.
Int J Chron Obstruct Pulmon Dis 15:3063-3077. 2020 - Impact of somatic mutations on prognosis in resected non-small-cell lung cancer: The Japan Molecular Epidemiology for lung cancer study.
Tamiya A, Koh Y, Isa SI, Kubo A, Ando M, Saka H, Yoshimoto N, Takeo S, Adachi H, Tagawa T, Kawashima O, Yamashita M, Kataoka K, Takenoyama M, Takeuchi Y, Watanabe K, Matsumura A, Kawaguchi T.
Cancer Med 9:2343-2351. 2020 - Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy.
Yamamoto N, Watanabe T, Yamada K, Nakai T, Suzumura T, Sakagami K, Yoshimoto N, Sato K, Tanaka H, Mitsuoka S, Asai K, Kimura T, Kanazawa H, Hirata K, Kawaguchi T.
J Thorac Dis 11:936-943. 2019 - Astaxanthin Suppresses Cigarette Smoke-Induced Emphysema through Nrf2 Activation in Mice.
Kubo H, Asai K, Kojima K, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
Mar Drugs 17:673. 2019 - Exercise Ameliorates Emphysema Of Cigarette Smoke-Induced COPD In Mice Through The Exercise-Irisin-Nrf2 Axis.
Kubo H, Asai K, Kojima K, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
Int J Chron Obstruct Pulmon Dis 14:2507-2516. 2019 - Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with EGFR-mutant non-small cell lung cancer.
Matsumoto Y, Sawa K, Fukui M, Oyanagi J, Izumi M, Ogawa K, Suzumura T, Watanabe T, Kaneda H, Mitsuoka S, Asai K, Kimura T, Yamamoto N, Koh Y, Kawaguchi T.
Cancer Sci 110:3244-3254. 2019 - Handgrip strength measurement in patients with chronic obstructive pulmonary disease: Possible predictor of exercise capacity.
Kyomoto Y, Asai K, Yamada K, Okamoto A, Watanabe T, Hirata K, Kawaguchi T.
Respir Investig 57:499-505. 2019 - Possible role of airway microvascular permeability on airway obstruction in patients with chronic obstructive pulmonary disease.
Kyomoto Y, Kanazawa H, Tochino Y, Watanabe T, Asai K, Kawaguchi T.
Respir Med 146:137-141. 2019 - Isoflavone Aglycones Attenuate Cigarette Smoke-Induced Emphysema via Suppression of Neutrophilic Inflammation in a COPD Murine Model.
Kojima K, Asai K, Kubo H, Sugitani A, Kyomoto Y, Okamoto A, Yamada K, Ijiri N, Watanabe T, Hirata K, Kawaguchi T.
Nutrients 11:2023. 2019 - A Polymorphism rs6726395 in Nrf2 Contributes to the Development of Emphysema-Associated Age in Smokers Without COPD.
Sugitani A, Asai K, Watanabe T, Suzumura T, Kojima K, Kubo H, Sato K, Ijiri N, Yamada K, Kimura T, Fukumoto S, Hirata K, Kawaguchi T.
Lung 197:559-564. 2019 - Effect of four neuraminidase inhibitors on influenza in Osaka, Japan: An eight- year survey.
Tochino Y, Yoshii N, Fujioka M, Hamazaki T, Kawaguchi T, Kakeya H, Shuto T. J Gen Fam Med 21:18-23. 2019 - Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTOR study.
Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M.
Int J Chron Obstruct Pulmon Dis 14:1789-1801. 2019 - Correlation between disease activity and serum ferritin in clinically amyopathic dermatomyositis with rapidly-progressive interstitial lung disease: a case report.
Yamada K, Asai K, Okamoto A, Watanabe T, Kanazawa H, Ohata M, Ohsawa M, Hirata K.
BMC Res Notes 11:34. 2018 - Evaluation of the severity of small airways obstruction and alveolar destruction in chronic obstructive pulmonary disease.
Kawamoto T, Kanazawa H, Tochino Y, Kawaguchi T.
Respir Med 141:159-164. 2018 - COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan.
Igarashi A, Fukuchi Y, Hirata K, Ichinose M, Nagai A, Nishimura M, Yoshisue H,Ohara K, Gruenberger JB.
Int J Chron Obstruct Pulmon Dis 13:2629-2641. 2018 - Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naive advanced non-squamous non-small cell lung cancer with EGFR mutations.
Tamiya M, Tamiya A, Shiroyama T, Takeoka S, Naito Y, Omachi N, Kimura Y, Morishita N, Suzuki H, Okamoto N, Okishio K, Kawaguchi T, Atagi S, Hirashima T.
Invest New Drugs 36:608-614. 2018 - Dose escalation study of concurrent chemoradiotherapy with the use of involved-field conformal radiotherapy and accelerated hyperfractionation in combination with cisplatin and vinorelbine chemotherapy for stage III non-small cell lung cancer: The final report.
Yoshimura N, Tada T, Matsumoto Y, Sawa K, Yoshimoto N, Suzumura T, Tanaka H, Mitsuoka S, Kimura T, Tamiya T, Hirashima T, Kawaguchi T, Kudoh S, Hosono M, Hirata K.
Am J Clin Oncol. 41: 967-971, 2018 - Chemotherapy versus Erlotinib as second-line treatment in patients with advanced Non-Small Cell Lung Cancer and wild-type epidermal growth factor receptor: an Individual Patient Data Analysis (IPD).
Garassino MC, Kawaguchi T, Gregorc V, Rulli E, Ando M, Marsoni S, Isa S, Novello S, Farina G, Barni S, Torri V, Cinquini M.
ESMO Open 3: e000327. 2018 - Identification of a Novel Rhizopus-specific Antigen by Screening with a Signal Sequence Trap and Evaluation as a Possible Diagnostic Marker of Mucormycosis.
Sato K, Oinuma KI, Niki M, Yamagoe S, Miyazaki Y, Asai K, Yamada K, Hirata K, Kaneko Y, Kakeya H.
Med Mycol 2017;55:713-719. - Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease.
Sugiyama Y, Asai K, Yamada K, Kureya Y, Ijiri N, Watanabe T, Kanazawa H, Hirata K.
Int J Chron Obstruct Pulmon Dis 2017;12:765-772. - Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
Okamoto A, Nojiri T, Konishi K, Tokudome T, Miura K, Hosoda H, Hino J, Miyazato M, Kyomoto Y, Asai K, Hirata K, Kangawa K.
Respir Res 2017;18:1. - PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
Sawa K, Koh Y, Kawaguchi T, Kambayashi S, Asai K, Mitsuoka S, Kimura T, Yoshimura N, Yoshimoto N, Kubo A, Saka H, Matsumura A, Wanibuchi H, Yamamoto N, Nishiyama N, Hirata K.
Lung Cancer 2017;112:96-101. - Interstitial Lung Disease Induced by Osimertinib for Epidermal Growth Factor Receptor (EGFR) T790M-positive Non-small Cell Lung Cancer.
Matsumoto Y, Kawaguchi T, Yamamoto N, Sawa K, Yoshimoto N, Suzumura T, Watanabe T, Mitsuoka S, Asai K, Kimura T, Yoshimura N, Kuwae Y, Hirata K.
Intern Med 2017;56:2325-2328. - Current usage and effectiveness of influenza medications and factors regarding the time taken to alleviate fever based on postcard questionnaireurvey.
Tochino Y, Fujioka M, Sakazaki H, Ikuno Y, Tochino R, Yoshii N, Shintaku H, Hirata K.
J Gen Fam Med 2017;18:386-392. - Asthma-COPD overlap syndrome-Coexistence of chronic obstructive pulmonary disease and asthma in elderly patients and parameters for their differentiation.
Tochino Y, Asai K, Shuto T, Hirata K.
J Gen Fam Med 2017;18:5-11. - Improved quality of life in asthma patients under long-term therapy: Assessed by AHQ-Japan.
Tohda Y, Iwanaga T, Sano H, Kume H, Hirata K, Ohkura N, Tachibana I, Nishimura Y, Matsumoto H, Minakata Y, Yoshikawa M, Fujimura M; Kansai & Hokuriku Academy for Asthma Treatment.
Int J Clin Pract 2017;71:e12898. - Study Design of VESUTOR: Efficacy of Tiotropium/Olodaterol on Lung Hyperinflation, Exercise Capacity, and Physical Activity in Japanese Patients with Chronic Obstructive Pulmonary Disease.
Ichinose M, Minakata Y, Motegi T, Ueki J, Seki T, Anzai T, Takizawa A, Gronke L, Hirata K.
Adv Ther 2017;34:1622-1635. - Multiplex Ultrasensitive Genotyping of Patients with Non-Small Cell Lung Cancer for Epidermal Growth Factor Receptor (EGFR) Mutations by Means of Picodroplet Digital PCR.
Watanabe M, Kawaguchi T, Isa SI, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kawashima O, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Watanabe K, Matsumura A, Koh Y.
EBioMedicine 2017;21:86-93. - Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
Soo RA, Kubo A, Ando M, Kawaguchi T, Ahn MJ, Ou SI.
Clin Lung Cancer 2017;18:535-542. - Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
Morimoto M, Okishio K, Akira M, Omachi N, Tamiya A, Asami K, Kawaguchi T, Atagi S.
Clin Lung Cancer 2017;18:e117-e127. - Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
Tambo Y, Hosomi Y, Sakai H, Nogami N, Atagi S, Sasaki Y, Kato T, Takahashi T, Seto T, Maemondo M, Nokihara H, Koyama R, Nakagawa K, Kawaguchi T, Okamura Y, Nakamura O, Nishio M, Tamura T.
Invest New Drugs 2017;35:217-226. - Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: Pooled analysis of SHINE and ARISE.
Asai K, Hirata K, Hashimoto S, Fukuchi Y, Kitawaki T, Ikeda K, Fogel R, Banerji D.
Respir Investig 2016;54:428-435. - Down-Regulation of Soluble α-Klotho is Associated with Reduction in Serum Irisin Levels in Chronic Obstructive Pulmonary Disease.
Kureya Y, Kanazawa H, Ijiri N, Tochino Y, Watanabe T, Asai K, Hirata K.
Lung 2016;194:345-351. - Impaired nuclear factor erythroid 2-related factor 2 expression increases apoptosis of airway epithelial cells in patients with chronic obstructive pulmonary disease due to cigarette smoking.
Yamada K, Asai K, Nagayasu F, Sato K, Ijiri N, Yoshii N, Imahashi Y, Watanabe T, Tochino Y, Kanazawa H, Hirata K.
BMC PulmMed 2016;16:27. - Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR.
Mitsuoka S, Kawaguchi T, Kubo A, Isa S, Asai K, Uji M, Watanabe T, Sawa K, Yoshimoto N, Oka T, Nakai T, Suzumura T, Tanaka H, Matsuura K, Kimura T, Yoshimura N, Kudoh S, Hirata K.
Expert Opin Pharmacother 2016;17:193-203. - Alectinib-Induced Erythema Multiforme and Successful Rechallenge with Alectinib in a Patient with Anaplastic Lymphoma Kinase-Rearranged Lung Cancer.
Kimura T, Sowa-Osako J, Nakai T, Ohyama A, Kawaguchi T, Tsuruta D, Ohsawa M, Hirata K.
Case Rep Oncol 2016;9:826-832. - Primary high-grade myxofibrosarcoma in the anterior mediastinum: A case report and review of the literature.
Yoon HE, Shimizu S, Tokura S, Okuma T, Kawaguchi T, Ito I, Akira M, Eimoto T, Kasai T, Matsumura A.
Cancer Treat Res Commun 2016;9:44-47. - Prospective Analysis of Oncogenic Driver Mutations and Environmental Factors: Japan Molecular Epidemiology for Lung Cancer Study.
Kawaguchi T, Koh Y, Ando M, Ito N, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Serizawa M, Tamiya A, Shimizu S, Yoshimoto N, Kubo A, Isa S, Saka H, Matsumura A.
J Clin Oncol 2016;34:2247-2257. - Primary Marginal Zone Lymphoma in the Posterior Mediastinum with Pleural Involvement.
Shimizu S, Inoue Y, Utsumi T, Okuma T, Kawaguchi T, Kasai T, Munakata S, Shibano M, Atagi S.
Intern Med 2016;55:2673-2677. - Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.
Tamiya M, Tamiya A, Yasue T, Nakao K, Omachi N, Shiroyama T, Tani E, Hamaguchi M, Morishita N, Suzuki H, Okamoto N, Okishio K, Kawaguchi T, Atagi S, Hirashima T.
Anticancer Res 2016;36:2939-2944. - An Intrinsic Strain of Colistin-resistant Acinetobacter Isolated from a Japanese Patient.
Takizawa E, Yamada K, Oinuma K, Sato K, Niki M, Namikawa H, Fujimoto H, Asai K, Kaneko Y, Kakeya H.
Intern Med 2016;55:2301-2306. - Reply: Secreted Brain-Derived Neurotrophic Factor and Asthma Severity.
Watanabe T, Fajt ML, Wenzel SE; All The Authors.
Am J Respir Cell Mol Biol 2016;54:297-298. - Definition of Chronic Obstructive Pulmonary Disease(COPD):Is the Latest GOLD Classification of Severity Still Valid？.
Asai K, Hirata K. In: Nakamura H, Aoshiba K,editors.
Chronic Obstructive Pulmonary Disease. 1st ed. Singapore: Springer, 2016. pp3-16. -
Sawa K, Kawaguchi T, Mitsuoka S, Kusutani N, Hirata K.
Internal Medicine Open access 2016 - Molecular Epidemiological Study on Passive Smoking and Estrogen Receptor Expression in Never-smokers with Non-small Cell Lung Cancer.
Yoshimoto N, Kawaguchi T, Isa S, Shimizu S, Tamiya A, Asai K, Kudo S and Hirata K.
Osaka City Medical Journal 62; 77-84, 2016 - A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.
Hirai F, Yamanaka T, Taguchi K, Daga H, Ono A, Tanaka K, Kogure Y, Shimizu J, Kimura T, Fukuoka J, Iwamoto Y, Sasaki H, Takeda K, Seto T, Ichinose Y, Nakagawa K, Nakanishi Y; West Japan Oncology Group.
Ann Oncol 2015;26:363-368. - Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer.
Isa SI, Kurahara Y, Yamamoto S, Tamiya A, Omachi N, Asami K, Okishio K, Utsumi T, Ito N, Yoon HE, Matsumura A, Atagi S, Kawaguchi T.
Oncol Lett 2015;9:927-929. - The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials.
Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
Oncologist 2015;20:307-315. - Intravascular synovial sarcoma of the pulmonary artery with massive pleural effusion: report of a case with a favorable response to Ifosfamide chemotherapy and palliative radiation therapy.
Maekura T, Shimizu S, Kawaguchi T, Morimoto M, Okuma T, Matsui H, Atagi S.
Intern Med 2015;54:1095-1098. - Life-threatening and Rapidly Growing Teratoma in the Anterior Mediastinum.
Omachi N, Kawaguchi T, Shimizu S, Okuma T, Kitaichi M, Atagi S, Yoon HE, Matsumura A.
Intern Med 2015;54:2487-2489. - Irisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary disease.
Ijiri N, Kanazawa H, Asai K, Watanabe T, Hirata K.
Respirology 2015;20:612-617. - Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR.
Watanabe M, Kawaguchi T, Isa S, Ando M, Tamiya A, Kubo A, Saka H, Takeo S, Adachi H, Tagawa T, Kakegawa S, Yamashita M, Kataoka K, Ichinose Y, Takeuchi Y, Sakamoto K, Matsumura A, Koh Y.
Clin Cancer Res 2015;21:3552-3560. - Anti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease.
Asai K, Kobayashi A, Makihara Y, Johnson M.
Int J Chron Obstruct Pulmon Dis 2015;10:803-811. - Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation.
Yoshimura N, Kudoh S, Mitsuoka S, Yoshimoto N, Oka T, Nakai T, Suzumira T, Matusura K, Tochino Y, Asai K, Kimura T, Kawaguchi T, Hirata K.
Lung Cancer 2015;90:65-70. - Randomized Phase II Study of Adjuvant Chemotherapy with Long-term S-1 versus Cisplatin+S-1 in Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer.
Iwamoto Y, Mitsudomi T, Sakai K, Yamanaka T, Yoshioka H, Takahama M, Yoshimura M, Yoshino I, Takeda M, Sugawara S, Kawaguchi T, Takahashi T, Ohta M, Ichinose Y, Atagi S, Okada M, Saka H, Nakagawa K, Nakanishi Y, Nishio K.
Clin Cancer Res 2015;21:5245-5252. - Primary Pleural Synovial Sarcoma Treated with Pazopanib.
Sugitani A, Asai K, Kojima K, Eguchi Y, Kawaguchi T, Ohsawa M, Hirata K.
Intern Med 2015;54:2051-2055. - Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
Shukuya T, Yamanaka T, Seto T, Daga H, Goto K, Saka H, Sugawara S, Takahashi T, Yokota S, Kaneda H, Kawaguchi T, Nagase S, Oguri T, Iwamoto Y, Nishimura T, Hattori Y, Nakagawa K, Nakanishi Y, Yamamoto N; West Japan Oncology Group.
Lancet Oncol 2015;16:1630-1638. - The Macroscopic Appearance of Computed Tomography-guided Needle Biopsy Specimens Correlates with Tumor Metastasis in Non-small Cell Lung Cancer.
Nakai T, Kimura T, Suzumura T, Yoshimoto N, Oka T, Yamamoto N, Matsuura K, Mitsuoka S, Asai K, Tochino Y, Yoshimura N, Kawaguchi T, Kudoh S, Matsuoka T, Ohsawa M, Hirata K.
Osaka City Med J 2015;61:105-112. - Molecular Analysis of Human Papillomavirus in Never-Smokers with Non-Small Cell Lung Cancer.
Isa S, Kurahara Y, Yamamoto S, Tamiya A, Omachi N, Asami K, Okishio K, Utsumi T, Ito N, Yoon H, Matsumura A, Atagi S, Kawaguchi T.
Oncology Letters 9: 927-929, 2015 - The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor. A meta-analysis of prospective randomized trials.
Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa S, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.
The Oncologist 2015;20:1?9 - Magnesium supplementation and high volume hydration reduce the renal toxicity caused by cisplatin-based chemotherapy in patients with lung cancer: a toxicity study.
Oka T, Kimura T, Suzumura T, Yoshimoto N, Nakai T, Yamamoto N, Matsuura K, Mitsuoka S, Yoshimura N, Kudoh S, Hirata K.
BMC Pharmacol Toxicol 2014;15:70. - Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
Ijiri N, Kanazawa H, Yoshikawa T, Hirata K.
Int J Chron Obstruct Pulmon Dis 2014;9:1235-1240. - Simultaneous assessment of hepatocyte growth factor and vascular endothelial growth factor in epithelial lining fluid from patients with COPD.
Kanazawa H, Tochino Y, Asai K, Hirata K.
Chest 2014;146:1159-1165. - Potential role of pentosidine on susceptibility to small airway closure in elderly and smoking asthma.
Kanazawa H, Kyoh S, Tochino Y, Asai K, Hirata K.
Respir Med 2014;108:709-715. - Epistatic effects of multiple receptor genes on pathophysiology of asthma - its limits and potential for clinical application.
Yoshikawa T, Kanazawa H, Fujimoto S, Hirata K.
Med Sci Monit 2014;20:64-71. - Analysis of the contributing factors to airway hyperresponsiveness by a forced oscillation technique in patients with asthma.
Imahashi Y, Kanazawa H, Ijiri N, Yoshii N, Tamagaki G, Asai K, Tochino Y, Hirata K.
Osaka City Med J 2014;60:53-62. - Role of Consolidation Chemotherapy after Concurrent Chemo-Radiotherapy in Locally Advanced Non?Small-Cell Lung Cancer.
Tsujino K, Kurata T, Kawaguchi T, Kubo A, Takada M, Ando M.
J Thoracic Oncol 2014; 9:e7-8. - Human papilloma virus in non-small cell lung cancer in never smokers：A systematic review of the literature.
Hasegawa Y, Ando M, Kubo A, Isa S, Yamamoto S, Tsujino K, Kurata T, Ou SH, Takada M, Kawaguchi T.
Lung Cancer 2014;83;8-13. - Stratification of Malignant Pleural Mesothelioma Prognosis Using Recursive Partitioning Analysis.
Suzuki H, Asami K, Hirashima T, Okamoto N, Yamadori T, Tamiya M, Morishita N, Shiroyama T, Takeoka S, Osa A, Azuma Y, Okishio K, Kawaguchi T, Atagi S, Kawase I.
Lung 2014; 192:191-195. - A Case of Large Cell Neuroendocrine Carcinoma Harboring an EML4-ALK Rearrangement with Resistance to the ALK Inhibitor Crizotinib.
Omachi N, Shimizu S, Kawaguchi T, Tezuka K, Kanazu M, Tamiya A, Asami K, Okishio K, Kitaichi M, Atagi S.
J Thorac Oncol 2014; 6: e40-e42. - Early pharmacodynamic assessment using 18F-fluorodeoxyglucose-positron emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.
Kanazu M, Maruyama K, Ando M, Asami K, Ishii M, Uehira K, Minomo S, Matsuda Y, Kawaguchi T, Atagi S, Ogawa Y, Kusunoki Y, Takada M, Kubo A.
Clin Lung Cancer 2014;15:182-187. - A pilot study of cisplatin and etoposide with or without radiotherapy for advanced malignant thymoma.
Tamiya A, Matsumura A, Tsuji T, Morimoto M, Asami K, Okishio K, Shimizu S, Yoon HE, Atagi S, Akira M, Kitaichi M, Kawaguchi T.
Anticancer Research 2014;34:2023-2027. - A case of pulmonary mucoepidermoid carcinoma responding to carboplatin and paclitaxel.
Sonobe S, Inoue K, Tachibana S, Siojiri M, Maeda T, Nakanishi N, Moritaka T, Kawaguchi T.
Jpn J Clin Oncol 2014;44:493-496. - Long-term complete response in disseminated pulmonary pleomorphic carcinoma induced by cisplatin plus gemcitabine.
Tamiya A, Asami K, Shimizu S, Matsumura A, Isa S, Okishio K, Kitaichi M, Atagi S, Takada M, Kawaguchi T, and Kubo A.
Internal Medicine 2014;53:2625-2628. - Will the requirement by the US FDA to simultaneously co-develop companion diagnostics (CDx) delay the approval of receptor tyrosine kinase inhibitors for RTK-rearranged (ROS1-, RET-, AXL-, PDGFR-a-, NTRK1-) non-small cell lung cancer globally？
Ou SH, Soo RA, Kubo A, Kawaguchi T, Ahn MJ.
Frontiers in Oncology eCollection 2014;4:1-8. - Randomized phase III trial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small cell lung cancer: Docetaxel and Erlotinib Lung cancer TriAl (DELTA).
Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A.
J Clin Oncol 32: 1902-1908, 2014 - Prospective assessment of continuation of erlotinib or gefitinib in patients with acquired resistance to erlotinib or gefitinib followed by the addition of pemetrexed.
Yoshimura N, Okishio K, Mitsuoka S, Kimura T, Kawaguchi T, Kobayashi M, Hirashima T, Daga H, Takeda K, Hirata K, Kudoh S.
J Thorac Oncol 2013;8:96-101. - Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs.
Umekawa K, Kimura T, Kudoh S, Suzumura T, Oka T, Nagata M, Mitsuoka S, Matsuura K, Nakai T, Yoshimura N, Kira Y, Hirata K.
BMC Res Notes 2013;6:139. - Dose escalation and feasibility study of amrubicin combined with cisplatin in previously untreated patients with advanced non-small cell lung cancer.
Yoshimura N, Kimura T, Mitsuoka S, Kyoh S, Tochino Y, Asai K, Ichimaru Y, Hirata K, Kudoh S.
Am J Clin Oncol 2013;36:105-109. - Skeletal-related events in advanced lung adenocarcinoma patients evaluated EGFR mutations.
Nagata M, Kudoh S, Mitsuoka S, Suzumura T, Umekawa K, Tanaka H, Matsuura K, Kimura T, Yoshimura N, Hirata K.
Osaka City Med J 2013;59:45-52. - Reaction of plasma adiponectin level in non-small cell lung cancer patients treated with EGFR-TKIs.
Umekawa K, Kimura T, Kudoh S, Suzumura T, Nagata M, Mitsuoka S, Matsuura K, Oka T, Yoshimura N, Kira Y, Hirata K.
Osaka City Med J 2013;59:53-60. - C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin.
Nagata M, Kimura T, Suzumura T, Kira Y, Nakai T, Umekawa K, Tanaka H, Matsuura K, Mitsuoka S, Yoshimura N, Oka T, Kudoh S, Hirata K.
Clin Med Insights Oncol 2013;7:31-39. - Whole-Genome Sequence of the Potentially Hypertransmissible Multidrug-Resistant Mycobacterium tuberculosis Beijing Strain OM-V02_005.
Tateishi Y, Tamaru A, Ogura Y, Niki M, Wada T, Yamamoto T, Hirata K, Hayashi T, Matsumoto S.
Genome Announc 2013;1:pii: e00608-00613. - Are leukocytes in asthmatic patients aging faster? A study of telomere length and disease severity.
Kyoh S, Venkatesan N, Poon AH, Nishioka M, Lin TY, Baglole CJ, Eidelman DH, Hamid Q.
J Allergy Clin Immunol 2013;132:480-482. - Plasma RANTES, IL-10, and IL-8 levels in non-small-cell lung cancer patients treated with EGFR-TKIs.
Umekawa K, Kimura T, Kudoh S, Suzumura T, Oka T, Nagata M, Mitsuoka S, Matsuura K, Nakai T, Yoshimura N, Kira Y, Hirata K.
BMC Res Notes. 2013.Apr; 6(1): 139 - C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin.
Nagata M, Kimura T, Suzumura T, Kira Y, Nakai T, Umekawa K, Tanaka H, Matsuura K, Mitsuoka S, Yoshimura N, Oka T, Kudoh S, Hirata K.
Clin Med Insights Oncol. 2013.Feb; 7: 31-9 - Comparison of adverse events of erlotinib with those of gefitinib in patients with non-small cell lung cancer: a case-control study in a Japanese population.
Suzumura T, Kimura T, Kudoh S, Umekawa K, Nagata M, Tanaka H, Mitsuoka S, Yoshimura N, Kira Y, Hirata K.
Osaka City Med J. 2012.Jun; 58(1): 25-34 - Association of airway pentosidine levels with bronchodilator response mediated by salbutamol administration in asthmatic patients.
Tamagaki G, Kanazawa H, Hirata K.
Pulm Pharmacol Ther. 2012.Dec; 25(6): 478-82 - Dose Escalation and Feasibility Study of Amrubicin Combined with Cisplatin in Previously Untreated Patients With Advanced Non-small-cell Lung Cancer.
Yoshimura N, Kimura T, Mitsuoka S, Kyoh S, Tochino Y, Asai K, Ichimaru Y,Hirata K, Kudoh S.
Am J Clin Oncol. 2012.Jan Epub ahead of print - Clinical outcome of amrubicin therapy according to the prior chemotherapy sensitivities of extensive small cell lung cancer.
Mitsuoka S, Kudoh S, Kimura T, Yoshimura N, Tanaka H, Suzumura T, Umekawa K, Nagata M, Ueda T, Hirata K.
Osaka City Med J. 2011.Dec; 57(2): 59-66 - Measurement of soluble perforin, a marker of CD8+ T lymphocyte activation in epithelial lining fluid
Shiratsuchi N, Asai K, Kanazawa H, Kyoh S, Tochino Y, Kodama T, Hirata K.
Respir Med. 2011 Dec;105(12):1885-90 - Validity of HMGB1 measurement in epithelial lining fluid in patients with COPD
Kanazawa H, Tochino Y, Asai K, Ichimaru Y, Watanabe T, Hirata K.
Eur J Clin Invest. 2011 Aug 25. doi: 10.1111/j.1365-2362.2011.02598.x. - Comparison of alveolar nitric oxide concentrations using two different methods for assessing small airways obstruction in asthma
Kobayashi D, Tochino Y, Kanazawa H, Ichimaru Y, Kyoh S, Asai K, Hirata K.
Respirology. 2011 Jul;16(5):862-8 - Association of six-minute walk distance (6MWD) with resting pulmonary function in patients with chronic obstructive pulmonary disease (COPD)
Fujimoto H, Asai K, Watanabe T, Kanazawa H, Hirata K.
Osaka City Med J. 2011 Jun;57(1):21-9 - Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride
Kimura T, Kudoh S, Hirata K
Clin Med Insights Oncol. 2011 Mar 3;5:23-34 - Potential roles of pentosidine in age-related and disease-related impairment of pulmonary functions in patients with asthma
Kanazawa H, Tochino Y, Kyoh S, Ichimaru Y, Asai K, Hirata K
J Allergy Clin Immunol. 2011 Apr;127(4):899-904 - Reaction of plasma hepatocyte growth factor levels in non-small cell lung cancer patients treated with EGFR-TKIs
Tanaka H, Kimura T, Kudoh S, Mitsuoka S, Watanabe T, Suzumura T, Tachibana K, Noguchi M, Yano S, Hirata K
Int J Cancer. 2011 Sep 15;129(6):1410-6. doi: 10.1002/ijc.25799. Epub 2011 Feb 26. - Increased levels of HMGB-1 and endogenous secretory RAGE in induced sputum from asthmatic patients
Watanabe T, Asai K, Fujimoto H, Tanaka H, Kanazawa H, Hirata K
Respir Med. 2011 Apr;105(4):519-25 - Validity of measurement of two specific biomarkers for the assessment of small airways inflammation in asthma.
Kanazawa H, Kyoh S, Asai K, Hirata K.
J Asthma. 2010 May;47(4):400-6. - Increased levels of N(epsilon)-(carboxymethyl)lysine in epithelial lining fluid from peripheral airways in patients with chronic obstructive pulmonary disease: a pilot study.
Kanazawa H, Kodama T, Asai K, Matsumura S, Hirata K.
Clin Sci (Lond). 2010 May 6;119(3):143-9. - Plasma concentration of amrubicinol in plateau phase in patients treated for 3 days with amrubicin is correlated with hematological toxicities.
Kimura T, Kudoh S, Mitsuoka S, Yoshimura N, Tanaka H, Asai K, Kyoh S, Tochino Y, Umekawa K, Hirata K.
Anticancer Drugs. 2009 Jul;20(6):513-8. - Phase II study of docetaxel and carboplatin in elderly patients with advanced non-small cell lung cancer.
Yoshimura N, Kudoh S, Kimura T, Mitsuoka S, Kyoh S, Tochino Y, Asai K, Kodama T, Ichimaru Y, Yana T, Hirata K.
J Thorac Oncol. 2009 Mar;4(3):371-5. - Monitoring of chemotherapy response in malignant pleural mesothelioma using fluorodeoxyglucose positron emission tomography.
Kimura T, Koyama K, Kudoh S, Kawabe J, Yoshimura N, Mitsuoka S, Shiomi S, Hirata K.
Intern Med. 2008;47(23):2053-6. Epub 2008 Dec 1. - Angiopoietin-2 as a contributing factor of exercise-induced bronchoconstriction in asthmatic patients receiving inhaled corticosteroid therapy.
Kanazawa H, Tochino Y, Asai K.
J Allergy Clin Immunol. 2008 Feb;121(2):390-5. Epub 2007 Nov 26. - A technological advance comparing epithelial lining fluid from different regions of the lung in smokers.
Kodama T, Kanazawa H, Tochino Y, Kyoh S, Asai K, Hirata K.
Respir Med. 2009 Jan;103(1):35-40. Epub 2008 Oct 18. - Comparison of N-epsilon-(Carboxymethyl)Lysine levels and percentage of eosinophils in induced sputum for assessment of small airway involvements in asthma.
Kyoh S, Kanazawa H, Tochino Y, Kodama T, Asai K, Hirata K.
Med Sci Monit. 2008 Jul;14(7):CR375-8. - Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD.
Umeda N, Yoshikawa T, Kanazawa H, Hirata K, Fujimoto S.
Respirology. 2008 May;13(3):346-52. - Correlations of health-related quality of life questionnaire results in asthma and allergic rhinitis: effects of a leukotriene receptor antagonist.
Ichimaru Y, Kanazawa H, Kamoi H, Kyoh S, Tochino Y, Kodama T, Hirata K.
J Int Med Res. 2008 May-Jun;36(3):559-66. - Nepsilon-(carboxymethyl)lysine, a major advanced glycation end product in exhaled breath condensate as a biomarker of small airway involvement in asthma.
Tochino Y, Kanazawa H, Ichimaru Y, Asai K, Kyoh S, Hirata K.
J Asthma. 2007 Dec;44(10):861-6. - Effects of tiotropium or combined therapy with salmeterol on hyperinflation in COPD.
Eguchi Y, Tateishi Y, Umeda N, Yoshikawa T, Kamoi H, Kanazawa H, Kudoh S, Hirata K, Fujimoto S.
Osaka City Med J. 2007 Jun;53(1):25-34. - Induced sputum analysis in asymptomatic young adults with bronchial hyperresponsiveness to methacholine.
Nomura N, Yoshikawa T, Kamoi H, Kanazawa H, Hirata K, Fujimoto S.
Respirology. 2007 Jul;12(4):516-22. - Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904).
Kudoh S, Takeda K, Nakagawa K, Takada M, Katakami N, Matsui K, Shinkai T, Sawa T, Goto I, Semba H, Seto T, Ando M, Satoh T, Yoshimura N, Negoro S, Fukuoka M.
J Clin Oncol. 2006 Aug 1;24(22):3657-63. - EKB-569, a new irreversible epidermal growth factor receptor tyrosine kinase inhibitor, with clinical activity in patients with non-small cell lung cancer with acquired resistance to gefitinib.
Yoshimura N, Kudoh S, Kimura T, Mitsuoka S, Matsuura K, Hirata K, Matsui K, Negoro S, Nakagawa K, Fukuoka M.
Lung Cancer. 2006 Mar;51(3):363-8. Epub 2005 Dec 20. - The association of adenocarcinoma and hemosputum in pulmonary malignancies.
Yamauchi S, Kudoh S, Kimura T, Yoshimura N, Mukohara T, Hirata K, Yoshikawa J.
Respiration. 2005 Sep-Oct;72(5):499-503. - Activated Akt expression has significant correlation with EGFR and TGF-alpha expressions in stage I NSCLC.
Mukohara T, Kudoh S, Matsuura K, Yamauchi S, Kimura T, Yoshimura N, Kanazawa H, Hirata K, Inoue K, Wanibuchi H, Fukushima S, Yoshikawa J.
Anticancer Res. 2004 Jan-Feb;24(1):11-7.